Navigation Links
Study finds genetic link between sleep disorders and depression in young children
Date:1/31/2009

Westchester, Ill. A study in the Feb. 1 issue of the journal SLEEP was the first to use twin data to examine the longitudinal link between sleep problems and depression. Results of this study demonstrate that sleep problems predict later depression; the converse association was not found. These findings are consistent with the theory that early treatment of sleep problems may protect children from the development of depression.

Results of the study indicate that the stability of sleep problems across time is mainly caused by genetic factors (46 percent of the genetic influences on sleep at age 10 were the same as those that influenced a child at age 8). The stability of depression is mainly caused by non-shared environmental influences (19 percent of the non-shared environmental influence on depression at age 10 remained the same from the age of eight).

According to lead author Alice M. Gregory, senior lecturer in the department of psychology at Goldsmiths College in London, the most surprising result of the study concerned the reasons why there may be links between sleep problems and depression at different points in a young person's life.

"We reported in a study previously, that genes were the most important factor in explaining the association between sleep problems and depression in eight year olds," said Gregory. "However, when we examined this issue at age 10, we found that genes were less important in explaining the association and that environmental influences had become more important. This could be because environmental experiences are becoming more relevant as children grow older and could therefore play a role in both sleep problems and depression."

The process thought to underlie the associations between sleep and depression reflects abnormalities that are known to be influenced by genetic variations. A longitudinal twin study was used in order to distinguish shared and non-shared environmental influe
'/>"/>

Contact: Kelly Wagner
kwagner@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Stanford study prevents pancreatic tumor growth in mice by inhibiting key protein
2. Study of Iraq veterans traumatic brain injuries to be conducted by UB researchers
3. Study confirms persistence of diversity problems in academic medicine
4. Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1
5. Perceptions and experiences of homeless youth vary by race, UCSF study shows
6. New Study: Protein in the Morning Helps Dieters Stay on Track and Keep Weight Off
7. New study explores the relationship between preterm birth and autism spectrum disorder
8. Study finds preemies more likely to score positive
9. Weight loss reduces incontinence in obese women, UCSF study shows
10. Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows
11. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Intermountain Healthcare ... with Stratus Video Interpreting for ... better communication and timely care for patients ... loss. Stratus’ video remote interpreting (VRI) services ... staff to quickly access qualified medical interpretation ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... 2015 Mediaplanet has joined forces with ... Skin Health is a cross-platform campaign with a ... of New York, Los Angeles, and Chicago, the campaign ... digital counterpart will reach a national audience through one ... the Skin Health campaign and Colorescience, click here ...
(Date:5/29/2015)... OncLive proudly announces the 2015 ... recognized by a panel of eminent oncologists for landmark ... Honorees will be introduced and celebrated TONIGHT at the ... 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, 2110 ... recognized for groundbreaking accomplishments, in fields including translational research, ...
(Date:5/29/2015)... May 29, 2015 Healthpointe is ... with specialists, physical therapy, and injections , For ... back and/or lower back pain, Healthpointe has a ... for herniated discs, disc protrusions and other causes ... , Healthpointe’s team of renowned surgeons are now ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... University of Texas MD Anderson Cancer Center has been awarded ... caused by head and neck cancer radiation treatment, can be ... The $2.7 million grant awarded by the National Cancer ... a perfect score from peer scientists evaluating grant proposals for ...
... Doheny HealthDay Reporter , TUESDAY, March 22 ... for the recommended five years protects women from breast ... drug and it also shields some women from cardiovascular ... heart-disease risk reduction were noted 15 years after starting ...
... 22 (HealthDay News) -- Nurses often don,t speak up ... workers making mistakes that could harm patients, new research ... steps to reduce medical errors through measures such as ... automated medication-dispensing systems. But the study, which included ...
... Jenifer Goodwin HealthDay Reporter , TUESDAY, March 22 ... called fibrates is on the rise in the United States ... improve health, researchers say. Fibrates are often prescribed to ... high levels of triglycerides, a harmful form of fat circulating ...
... work in Lewy body dementia , the Harry T. ... gift, pledged over four years. Lewy body dementia, which combines ... , is the second most common form of dementia in ... and video resources, including excerpts from an interview with Drs. ...
... University has started recruiting patients for a new ... whether the cholesterol-reducing drug rosuvastatin is effective in ... laboratory research and population studies have shown that ... lowers cholesterol, had fewer colon polyps, which can ...
Cached Medicine News:Health News:UT MD Anderson receives grant for study of acupuncture in cancer 2Health News:Tamoxifen May Offer Long-Term Heart, Cancer Protection 2Health News:Tamoxifen May Offer Long-Term Heart, Cancer Protection 3Health News:Study: Reluctance to Speak Up Encourages Medical Errors 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 3Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 4Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 3Health News:Jefferson clinical trial: Can a cholesterol drug prevent colon cancer? 2
(Date:5/29/2015)... MENLO PARK, Calif. , May 29, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, presented additional ... Cancer Research (AACR) Advances in Brain Cancer Research ... product candidate VAL-083 (dianhydrogalactitol) to treat ...
(Date:5/29/2015)... OAKS, Calif. , May 29, 2015 /PRNewswire/ ... pooled data from two pivotal Phase 3, global, ... calcimimetic, for the treatment of secondary hyperparathyroidism (SHPT) ... hemodialysis. Both studies met the primary endpoint, demonstrating ... AMG 416 groups achieved a greater than 30 ...
(Date:5/28/2015)... , May 28, 2015  Eli Lilly and Company ... its previously announced cash tender offer for up to $1.6 ... securities. Holders of notes who tendered, and did ... New York City time, on May ... for purchase by Lilly, are eligible to receive the total ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5
... (Nasdaq: MYL ) today confirmed that the ... Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation in connection with ... with the U.S. Food and Drug Administration (FDA) for ... 0.05 mg/day, 0.075 mg/day and 0.1 mg/day. This product ...
... would tax the companies that manage prescription drug benefits ... owners they contract with – will drive up prescription ... Management Association (PCMA), the trade group for America,s pharmacy ... of America,s businesses, state and federal government agencies, and ...
Cached Medicine Technology:Mylan Confirms First-to-File Patent Challenge Relating to Vivelle-Dot® 2PCMA: Mississippi's 'Secret Prescription Drug Tax' Will Raise Costs 2
Inquire...
...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Inquire...
Medicine Products: